Study guide
11.4 Invasive and Non-Invasive Hemodynamic and Respiratory Monitoring
EDAIC Part I European Diploma in Anaesthesiology and Intensive Care
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: The EDAIC Part I Examination
1.1 EDAIC Part I Exam Format, Scoring and Multiple True/False Strategy
2 Chapter 2: Anatomy for Anaesthesia and Intensive Care
2.1 Functional Anatomy of the Upper Airway, Larynx, and Tracheobronchial Tree 2.2 Neuraxial Anatomy: Spine, Spinal Cord, Meninges, and Spaces 2.3 Vascular Anatomy for Central and Peripheral Cannulation 2.4 Peripheral Nerve Plexuses and Autonomic Nervous System Pathways 2.5 Thoracic Anatomy: Chest Wall, Intercostal Spaces, Pleura, Mediastinum and Heart
3 Chapter 3: Respiratory and Cardiovascular Physiology
3.1 Respiratory Mechanics, Lung Volumes, and Work of Breathing 3.2 Ventilation-Perfusion Relationships, Shunt, and Gas Exchange 3.3 Control of Breathing, Hypoxia, Altitude and Hyperbaric Physiology 3.4 Cardiac Cycle, Electrophysiology, and Ventricular Function 3.5 Vascular Resistance, Microcirculation, and Systemic Hemodynamics
4 Chapter 4: Neurophysiology, Renal, Hepatic and Acid-Base Physiology
4.1 Cerebral Blood Flow, Intracranial Pressure, and CSF Dynamics 4.2 Renal Physiology, Glomerular Filtration, and Tubular Transport 4.3 Hepatic Blood Flow, Metabolism, and Clearance 4.4 Acid-Base Regulation, Buffering Systems, and Stewart Approach
5 Chapter 5: Endocrine and Haematological Physiology
5.1 Endocrine Physiology and the Neuroendocrine Stress Response 5.2 Haemostasis Physiology, Coagulation Testing and Inherited Bleeding Disorders
6 Chapter 6: Special Patient Physiology: Maternal, Paediatric and Geriatric
6.1 Maternal Physiological Adaptations to Pregnancy and Uteroplacental Flow 6.2 Neonatal and Paediatric Physiological Differences 6.3 Physiological Changes of Ageing and Thermoregulation
7 Chapter 7: General Pharmacological Principles and Inhalational Anaesthetics
7.1 Pharmacokinetic Principles, Compartmental Models, and Clearance 7.2 Pharmacodynamic Mechanisms, Receptor Theory, and Drug Interactions 7.3 Physical Properties, Uptake, and Distribution of Volatile Anaesthetics 7.4 Minimum Alveolar Concentration (MAC), Organ Effects, and Toxicity
8 Chapter 8: Intravenous Agents, Neuromuscular Blockade and Analgesics
8.1 Intravenous Induction Agents: Propofol, Etomidate, Ketamine, and Barbiturates 8.2 Neuromuscular Blocking Agents: Depolarizing and Non-Depolarizing Drugs 8.3 Neuromuscular Monitoring and Reversal: Anticholinesterases and Sugammadex 8.4 Opioid Pharmacology, Receptors, and Non-Opioid Analgesic Agents
9 Chapter 9: Cardiovascular Drugs, Autonomic Pharmacology and Local Anaesthetics
9.1 Inotropes, Vasopressors, and Inodilators in Perioperative Care 9.2 Antiarrhythmic, Antihypertensive, and Beta-Adrenergic Antagonist Drugs 9.3 Local Anaesthetic Pharmacology, Toxicity (LAST), and Lipid Emulsion Therapy
10 Chapter 10: Haematological and Internal Medicine Pharmacology
10.1 Anticoagulant, Antiplatelet and Haemostatic Drugs and Their Reversal 10.2 Internal Medicine Drugs: Endocrine, Respiratory, Psychiatric and Antiepileptic Agents and Their Anaesthetic Interactions
11 Chapter 11: Physics, Clinical Measurement and Medical Equipment
11.1 Physical Gas Laws, Fluid Dynamics, and Resistance Principles 11.2 Anaesthetic Machines, Gas Supply Pipelines, Cylinders, and Safety Mechanisms 11.3 Breathing Systems, Vaporizer Mechanics, and Scavenging Systems 11.4 Invasive and Non-Invasive Hemodynamic and Respiratory Monitoring
12 Chapter 12: Electrical Safety, Temperature, Humidity and Gas Analysis
12.1 Electricity, Electrical Safety, Diathermy, Defibrillation, Implanted Devices and Fire 12.2 Temperature Measurement, Humidity, Gas Analysis and SI Units
13 Chapter 13: Biostatistics, Clinical Trials and Evidence Appraisal
13.1 Descriptive Statistics, Distributions, and Parametric vs Non-Parametric Tests 13.2 Hypothesis Testing, Power, Type I/II Errors, and Confidence Intervals 13.3 Clinical Study Designs, Bias, and Diagnostic Test Performance (Sensitivity, Specificity, ROC)
14 Chapter 14: General Anaesthesia, Preoperative Evaluation and Airway Management
14.1 Preoperative Risk Assessment, Cardiovascular Risk Indices, and Fasting Guidelines 14.2 The Difficult Airway: Assessment, Algorithms, and Rescue Oxygenation 14.3 Intraoperative Fluid Therapy, Goal-Directed Hemodynamics, and Blood Conservation 14.4 Post-Anaesthesia Care Unit (PACU) Management, Emergence, and Postoperative Nausea/Vomiting
15 Chapter 15: Coexisting Disease and Preoperative Investigations
15.1 Interpreting Investigations: ECG, Chest Radiograph, Lung Function and Blood Tests 15.2 Coexisting Disease I: Asthma, COPD, Obstructive Sleep Apnoea, Obesity, Liver and Renal Disease 15.3 Endocrine Disease and Emergencies: Diabetes, DKA and HHS, Thyroid, Adrenal, Phaeochromocytoma and Carcinoid 15.4 Coexisting Disease II: Neuromuscular and Neurological Disease
16 Chapter 16: Subspecialty Anaesthesia: Cardiothoracic, Vascular and Neuroanaesthesia
16.1 Anaesthesia for Cardiac Surgery and Cardiopulmonary Bypass Management 16.2 Thoracic Anaesthesia, One-Lung Ventilation, and Major Vascular Surgery 16.3 Neuroanaesthesia: Craniotomy, Sitting Position, and Traumatic Brain Injury
17 Chapter 17: Obstetric, Paediatric and Ambulatory Anaesthesia
17.1 Obstetric Analgesia and Anaesthesia: Labour, Caesarean Delivery, and High-Risk Conditions 17.2 Paediatric Anaesthesia: Induction, Airway Management, and Emergencies 17.3 Ambulatory Day-Surgery Selection, Premedication, and Elderly Patient Anaesthesia
18 Chapter 18: Anaesthetic Complications and Specialty Settings
18.1 Anaesthetic Complications: Accidental Awareness, Aspiration, Positioning Injuries, Visual Loss and Dental Damage 18.2 Anaesthesia for ENT and Laser Airway Surgery, Ophthalmic Surgery, and Laparoscopic and Robotic Surgery
19 Chapter 19: Regional Anaesthesia and Acute/Chronic Pain Management
19.1 Neuraxial Techniques: Spinal, Epidural, and Caudal Anaesthesia 19.2 Upper and Lower Limb Peripheral Nerve and Fascial Plane Blocks 19.3 Multimodal Acute Postoperative Pain Management and ERAS Pathways 19.4 Chronic and Neuropathic Pain Syndromes and Interventional Management 19.5 Palliative Symptom Control, Psychological Aspects of Pain and Multidisciplinary Pain Management
20 Chapter 20: Intensive Care Medicine: Ventilation, Shock and Organ Support
20.1 Acute Respiratory Distress Syndrome (ARDS) and Mechanical Ventilation Strategies 20.2 Sepsis-3 Definitions, Septic Shock, and Hemodynamic Resuscitation 20.3 Acute Kidney Injury, Indications for Dialysis, and Continuous Renal Replacement Therapy 20.4 ICU Sedation, Delirium, Weaning, and Brain Death Determination
21 Chapter 21: Intensive Care Medicine: Admission, Nutrition, Infection and Electrolytes
21.1 ICU Admission, Severity Scoring, Nutrition and Routine Prophylaxis 21.2 Antimicrobial Therapy, Stewardship and ICU-Acquired Infections 21.3 Electrolyte Disorders: Sodium, Potassium, Calcium, Magnesium and Phosphate
22 Chapter 22: Intensive Care and Emergency Medicine: Neurocritical Care, Poisoning and Cardiorespiratory Emergencies
22.1 Neurocritical Care: Subarachnoid Haemorrhage, Stroke, Status Epilepticus and Acute Neuromuscular Failure 22.2 Acute Poisoning: Toxidromes, Decontamination and Specific Antidotes 22.3 Acute Cardiorespiratory Emergencies: Pulmonary Embolism, Acute Severe Asthma and COPD, Non-Invasive Support and Acute Heart Failure
23 Chapter 23: Resuscitation, Perioperative Emergencies and Professional Ethics
23.1 Advanced Life Support (ALS) Guidelines and Perioperative Cardiac Arrest 23.2 Perioperative Crises: Malignant Hyperthermia and Severe Anaphylaxis 23.3 Major Trauma, Hemorrhagic Shock, and Massive Transfusion Protocols 23.4 Professional Ethics, Informed Consent, Patient Safety, and Helsinki Declaration
24 Chapter 24: Newborn, Paediatric and Obstetric Emergencies
24.1 Newborn Life Support and Paediatric Life Support 24.2 Obstetric Emergencies: Maternal Collapse, Amniotic Fluid Embolism, Uterine Inversion and Resuscitative Hysterotomy
25 Chapter 25: Burns, Environmental Emergencies and Patient Transport
25.1 Burns, Inhalation Injury, Drowning, Hypothermia, Heat Illness and Decompression Illness 25.2 Prehospital Care and Intra- and Inter-Hospital Transport of the Critically Ill
11.4 Invasive and Non-Invasive Hemodynamic and Respiratory Monitoring
Key Takeaways Explain This Topic AI
Pulse oximeters use dual wavelengths (660 nm red for deoxyhemoglobin and 940 nm infrared for oxyhemoglobin) to calculate the ratio of ratios; carboxyhemoglobin causes falsely normal readings, while methemoglobin locks displayed S p O 2 SpO_2 Sp O 2 near 85%.
Capnography utilizes 4.26 μ \mu μ m infrared absorption to track four distinct phases of respiration, where obstructive airway disease produces a pathognomonic shark-fin waveform and rebreathing produces an elevated Phase I baseline.
Arterial line transducer-tubing systems require a natural frequency exceeding 25 Hz and an optimal damping coefficient of 0.64-0.70; underdamping causes falsely high systolic and low diastolic readings while preserving mean arterial pressure.
Transducer leveling produces a hydrostatic offset of 0.74 mmHg per centimeter of vertical displacement (1 mmHg = 1.36 cmH2O), requiring alignment to the tragus to monitor cerebral perfusion pressure in sitting craniotomies.
Processed EEG indices like BIS target 40-60 for surgical anaesthesia, but exhibit paradoxical elevations with ketamine and nitrous oxide and non-pharmacological suppression during profound hypothermia or cerebral ischemia.
Last updated: October 2026
11.4 Invasive and Non-Invasive Hemodynamic and Respiratory Monitoring
Clinical monitoring in anaesthesia translates physical phenomena—optical light absorption, infrared spectral attenuation, hydraulic pressure transduction, and microvoltage neuro-electric potentials—into quantitative physiological metrics. Understanding the physical principles, dynamic response characteristics, and artifact etiologies of clinical monitors is essential to maintain patient safety.
Pulse Oximetry: Spectrophotometry and Optical Plethysmography
Pulse oximetry provides non-invasive, continuous measurement of arterial hemoglobin oxygen saturation ( S p O 2 SpO_2 Sp O 2 ) by combining two physical techniques: spectrophotometry (measuring light absorption across specific wavelengths) and optical plethysmography (identifying pulsatile vascular volume changes).
The Beer-Lambert Law
Optical absorption follows the Beer-Lambert Law : I = I 0 e − ϵ ( λ ) c d ⟹ A = log 10 ( I 0 I ) = ϵ ( λ ) ⋅ c ⋅ d I = I_0 e^{-\epsilon(\lambda) c d} \quad \implies \quad A = \log_{10}\left(\frac{I_0}{I}\right) = \epsilon(\lambda) \cdot c \cdot d I = I 0 e − ϵ ( λ ) c d ⟹ A = lo g 10 ( I I 0 ) = ϵ ( λ ) ⋅ c ⋅ d where:
- I 0 I_0 I 0 = incident light intensity
- I I I = transmitted light intensity
- A A A = total optical absorbance
ϵ ( λ ) \epsilon(\lambda) ϵ ( λ ) = extinction coefficient of the absorbing substance at wavelength λ \lambda λ
- c c c = concentration of the absorbing substance
- d d d = optical path length through the tissue
- Dual-Wavelength Measurement Physics
Pulse oximeter probes contain two miniature light-emitting diodes (LEDs) and a single photodiode detector:
Red Light ( 660 nm 660\text{ nm} 660 nm ): Deoxygenated hemoglobin ( H b Hb H b ) has an extinction coefficient approximately 10 10 10 times higher than oxygenated hemoglobin ( H b O 2 HbO_2 H b O 2 ). Therefore, deoxygenated blood strongly absorbs 660 nm 660\text{ nm} 660 nm red light.
Infrared Light ( 940 nm 940\text{ nm} 940 nm ): Oxygenated hemoglobin ( H b O 2 HbO_2 H b O 2 ) has a higher extinction coefficient than deoxygenated hemoglobin ( H b Hb H b ). Therefore, oxygenated blood absorbs 940 nm 940\text{ nm} 940 nm infrared light more avidly.
The Isobestic Point: A wavelength where two chemical species possess identical extinction coefficients (e.g., 590 nm 590\text{ nm} 590 nm and 805 nm 805\text{ nm} 805 nm for H b Hb H b and H b O 2 HbO_2 H b O 2 ). At an isobestic point, light absorption depends strictly on total hemoglobin concentration, independent of oxygen saturation.
Photoplethysmography and the "Ratio of Ratios"
To isolate arterial blood from non-arterial absorbers, the oximeter separates the detected photoplethysmographic signal into two components:
AC Component (Pulsatile): Caused by systolic arterial pulsation expanding the arteriolar vascular bed, rhythmically modulating optical path length ( d d d ).
DC Component (Non-Pulsatile / Baseline): Constant light attenuation by venous blood, capillary beds, connective tissue, bone, and skin pigments.
The monitor calculates the dimensionless Ratio of Ratios ( R R R ): R = A C 660 / D C 660 A C 940 / D C 940 R = \frac{AC_{660} / DC_{660}}{AC_{940} / DC_{940}} R = A C 940 / D C 940 A C 660 / D C 660
Calibration Curve: Because tissue scattering prevents direct mathematical calculation from Beer-Lambert equations, microprocessors map R R R against an empirical calibration curve obtained from healthy human volunteers:
- R = 0.4 ⟹ S p O 2 = 100 % R = 0.4 \implies SpO_2 = 100\% R = 0.4 ⟹ Sp O 2 = 100%
- R = 1.0 ⟹ S p O 2 = 85 % R = 1.0 \implies SpO_2 = 85\% R = 1.0 ⟹ Sp O 2 = 85%
Volunteers cannot safely be desaturated much below about 70 − 75 % 70-75\% 70 − 75% , so readings below that range are extrapolated and less accurate.
Dyshemoglobinemias and Artifacts
Carboxyhemoglobin ( C O H b COHb CO H b ): C O H b COHb CO H b absorbs light at 660 nm 660\text{ nm} 660 nm with an extinction coefficient virtually identical to H b O 2 HbO_2 H b O 2 , while absorbing minimally at 940 nm 940\text{ nm} 940 nm . Standard two-wavelength pulse oximeters cannot distinguish C O H b COHb CO H b from H b O 2 HbO_2 H b O 2 . The monitor counts C O H b COHb CO H b as H b O 2 HbO_2 H b O 2 , displaying a falsely normal or elevated S p O 2 SpO_2 Sp O 2 (e.g., reading 98 % 98\% 98% when true arterial fractional saturation S a O 2 SaO_2 S a O 2 is 65 % 65\% 65% ). Accurate diagnosis requires multi-wavelength co-oximetry .
Methemoglobinemia ( M e t H b MetHb M e t H b , Ferric F e 3 + Fe^{3+} F e 3 + Iron): M e t H b MetHb M e t H b exhibits very high and virtually identical extinction coefficients at both 660 nm 660\text{ nm} 660 nm and 940 nm 940\text{ nm} 940 nm . As M e t H b MetHb M e t H b concentrations exceed 20 − 30 % 20-30\% 20 − 30% , the ratio R R R is mathematically forced toward 1.0 1.0 1.0 . Looking at the calibration curve, R = 1.0 R = 1.0 R = 1.0 corresponds to an S p O 2 SpO_2 Sp O 2 locked at approximately 85 % 85\% 85% , regardless of true arterial oxygenation (underestimating true saturation if S a O 2 > 85 % SaO_2 > 85\% S a O 2 > 85% , overestimating if S a O 2 < 85 % SaO_2 < 85\% S a O 2 < 85% ).
Intravenous Dyes:
Methylene Blue: Optical absorption peak at 668 nm 668\text{ nm} 668 nm (closely matching the red LED). Induces a precipitous, false drop in S p O 2 SpO_2 Sp O 2 to 60 − 65 % 60-65\% 60 − 65% lasting several minutes.
Indocyanine Green and Indigo Carmine: Induce minor, transient false drops in S p O 2 SpO_2 Sp O 2 .
Physiological Limitations: Severe hypoperfusion (hypovolemic shock, severe vasoconstriction, hypothermia, low cardiac output) diminishes pulsatile A C AC A C amplitude below the signal-to-noise detection threshold. Venous pulsations (severe tricuspid regurgitation, tight probe application) introduce an A C AC A C signal into venous blood, causing false underestimation of S p O 2 SpO_2 Sp O 2 .
Infrared Capnography: Physics and Waveform Morphology
Capnography provides continuous, real-time monitoring of carbon dioxide concentration in respiratory gases.
Physical Measurement Principle: NDIR Spectroscopy
Capnometers utilize Non-Dispersive Infrared (NDIR) Spectroscopy . Asymmetrical polyatomic gas molecules absorb specific wavelengths of infrared radiation through rotational-vibrational excitation. The carbon dioxide molecule ( O = C = O O=C=O O = C = O ) absorbs infrared radiation strongly at a narrow absorption band of 4.26 μ m 4.26\text{ }\mu\text{m} 4.26 μ m (with zero absorption by symmetrical diatomic molecules like O 2 O_2 O 2 and N 2 N_2 N 2 ). Transmitted IR energy is converted into a P C O 2 P_{CO_2} P C O 2 value via Beer-Lambert kinetics.
Mainstream vs. Sidestream Analyzers
Mainstream (In-Line): The sensor cell is placed directly at the airway between the ETT and breathing circuit.
Advantages: Instantaneous response time ( < 50 ms <50\text{ ms} < 50 ms ), zero transit delay, no scavenging required.
Disadvantages: Adds mechanical dead space ( 5 − 10 mL 5-10\text{ mL} 5 − 10 mL ), heavy at the airway (risking accidental extubation), optical windows prone to condensation and mucus contamination, heated sensor ( 41 − 42 ° C 41-42°\text{C} 41 − 42° C ) risks thermal skin burns.
Sidestream (Diverting): Continuously aspirates gas from the airway connector via a fine capillary sampling tube at 150 to 200 mL/min 150\text{ to }200\text{ mL/min} 150 to 200 mL/min to an internal analyzer in the monitor.
Advantages: Minimal weight at the airway, compatible with awake/non-intubated patients via nasal prongs.
Disadvantages: Transit time delay of 1 − 3 seconds 1-3\text{ seconds} 1 − 3 seconds , waveform dispersion/blunting along sampling tubing, water trap obstruction by condensation.
- The Normal Capnogram Waveform PCO2
- (mmHg) Phase III (Alveolar Plateau)
- 40 | /------------------* (ETCO2)
- | / |
- | Phase II / | Phase 0
- | (Upstroke) / | (Inspiratory Downstroke)
- | / |
- 0 +-------------/ +-----------------
- Phase I (Baseline) Phase I (Next Breath)
Phase I (Inspiratory Baseline): Exhalation of gas from anatomical dead space containing zero C O 2 CO_2 C O 2 ( P C O 2 = 0 mmHg P_{CO_2} = 0\text{ mmHg} P C O 2 = 0 mmHg ). Baseline must touch zero.
Phase II (Expiratory Upstroke): Rapid upstroke representing transitional mixing of C O 2 CO_2 C O 2 -free anatomical dead space gas with early alveolar gas.
Phase III (Alveolar Plateau): Exhalation of alveolar gas from across lung units. Slopes gently upward because slow-emptying alveoli have lower ventilation-perfusion ( V / Q V/Q V / Q ) ratios and higher P C O 2 P_{CO_2} P C O 2 . The peak value at the very end of expiration is the End-Tidal C O 2 CO_2 C O 2 ( E T C O 2 ETCO_2 ETC O 2 ) .
Phase 0 (Inspiratory Downstroke): Rapid, steep descent back to zero as fresh, C O 2 CO_2 C O 2 -free gas is inhaled.
Alveolar-to-Arterial C O 2 CO_2 C O 2 Gradient
Under normal physiological conditions, end-tidal C O 2 CO_2 C O 2 is slightly lower than arterial P a C O 2 P_a CO_2 P a C O 2 : P a C O 2 − E T C O 2 ≈ 2 − 5 mmHg ( 0.3 − 0.7 kPa ) P_a CO_2 - ETCO_2 \approx 2-5\text{ mmHg} \quad (0.3-0.7\text{ kPa}) P a C O 2 − ETC O 2 ≈ 2 − 5 mmHg ( 0.3 − 0.7 kPa ) This gradient is caused by normal alveolar dead space ( V D / V T V_D / V_T V D / V T ) —alveoli that are ventilated but under-perfused ( V / Q → ∞ V/Q \rightarrow \infty V / Q → ∞ ), diluting alveolar gas with 0 mmHg C O 2 0\text{ mmHg } CO_2 0 mmHg C O 2 .
Pathological Widening of the Gradient: Any condition that increases alveolar dead space widens the P a C O 2 − E T C O 2 P_a CO_2 - ETCO_2 P a C O 2 − ETC O 2 gradient, causing E T C O 2 ETCO_2 ETC O 2 to plummet relative to P a C O 2 P_a CO_2 P a C O 2 :
- Pulmonary thromboembolism or air embolism
- Severe hypovolemia, hemorrhage, or acute cardiac arrest (loss of pulmonary perfusion)
- Excessive positive end-expiratory pressure (PEEP) overdistending non-dependent alveoli
- Chronic obstructive pulmonary disease (COPD)
- Pathological Capnography Waveforms
Bronchospasm / Obstructive Airway Disease: Prolonged, sloped Phase II and steep upward-sloping Phase III, producing the classic "shark-fin" appearance . Caused by heterogeneous airway narrowing and prolonged expiratory time constants across obstructed lung units.
Rebreathing of Carbon Dioxide: Elevation of the Phase I baseline ( > 0 mmHg >0\text{ mmHg} > 0 mmHg ) . Caused by an exhausted soda lime canister, channeling within the absorbent, or an incompetent expiratory unidirectional valve in a circle system.
Curare Cleft: A distinct dip or notch in the final third of the Phase III alveolar plateau, representing brief spontaneous diaphragmatic contraction against the ventilator as neuromuscular blockade wears off.
Cardiogenic Oscillations: Small, rhythmic ripples on Phase III and Phase 0, caused by the mechanical pulsation of the heart displacing gas within adjacent lung segments during low respiratory rates.
Sudden Loss of E T C O 2 ETCO_2 ETC O 2 to Zero: Immediate diagnostic emergency indicating circuit disconnection, accidental tracheal extubation, complete airway obstruction, esophageal intubation, or cardiac arrest.
Invasive Arterial Blood Pressure (IABP) Monitoring
Invasive arterial catheterization provides beat-to-beat blood pressure tracking and arterial blood gas sampling.
Transducer Physical Architecture
The system comprises an intra-arterial cannula, fluid-filled non-compliant tubing, stopcocks, a continuous flush device ( 3 − 4 mL/hr 3-4\text{ mL/hr} 3 − 4 mL/hr heparinized saline pressurized to 300 mmHg 300\text{ mmHg} 300 mmHg ), and a piezoresistive strain gauge transducer.
Piezoresistive Transduction: Hydraulic pressure pulses flex a silicon diaphragm embedded with a Wheatstone bridge circuit . Microscopic deformation alters electrical resistance, converting physical pressure into an electrical voltage signal proportional to arterial pressure.
Dynamic Response: Natural Frequency and Damping
The fluid-filled catheter-tubing-transducer assembly is a mechanical harmonic oscillator with distinct dynamic physical properties:
Natural Resonant Frequency ( f n f_n f n ): The frequency at which the system oscillates freely when perturbed. The arterial pressure wave consists of a fundamental frequency equal to the heart rate ( 1 − 2 Hz 1-2\text{ Hz} 1 − 2 Hz ) plus multiple harmonic frequencies up to the 10th harmonic ( 10 − 20 Hz 10-20\text{ Hz} 10 − 20 Hz ). To prevent resonant amplification, the system's natural frequency must be at least 5 times the fundamental frequency: clinically, f n > 25 Hz f_n > 25\text{ Hz} f n > 25 Hz is mandatory .
Damping Coefficient ( ζ \zeta ζ ): Quantifies the viscous friction that opposes oscillation and absorbs energy from the pressure wave. Optimal damping is ζ = 0.64 − 0.70 \zeta = 0.64-0.70 ζ = 0.64 − 0.70 (adequate clinical range: 0.6 − 0.8 0.6-0.8 0.6 − 0.8 ).
The Fast-Flush (Square-Wave) Test
Pulling and abruptly releasing the high-pressure flush valve sends a 300 mmHg 300\text{ mmHg} 300 mmHg square wave through the system, inducing free oscillation:
f n f_n f n Calculation: f n = Paper/Sweep Speed (mm/s) Wavelength of one oscillation cycle (mm) f_n = \frac{\text{Paper/Sweep Speed (mm/s)}}{\text{Wavelength of one oscillation cycle (mm)}} f n = Wavelength of one oscillation cycle (mm) Paper/Sweep Speed (mm/s) .
Damping Ratio ( ζ \zeta ζ ): Calculated from the amplitude ratio of two consecutive oscillation peaks ( A 2 / A 1 A_2 / A_1 A 2 / A 1 ).
Dynamic State Waveform Morphology Fast-Flush Appearance Impact on Systolic BP Impact on Diastolic BP Impact on Mean Arterial Pressure (MAP)
Underdamped ( ζ < 0.6 \zeta < 0.6 ζ < 0.6 ) Spiked, narrow systolic peak, exaggerated dicrotic notch Excessive resonant ringing ( > 2 − 3 >2-3 > 2 − 3 oscillations before returning to baseline) Falsely HIGH (overshoot) Falsely LOW (undershoot) ACCURATE (area under curve is conserved)
Optimal ( ζ ≈ 0.7 \zeta \approx 0.7 ζ ≈ 0.7 ) Crisp upstroke, clear dicrotic notch 1 − 2 1-2 1 − 2 oscillations before baseline recovery ACCURATE ACCURATE ACCURATE
Overdamped ( ζ > 0.8 \zeta > 0.8 ζ > 0.8 ) Sluggish, blunted upstroke, loss of dicrotic notch Sluggish return to baseline ( < 1 <1 < 1 oscillation ) Falsely LOW Falsely HIGH ACCURATE
Causes of Overdamping: Air bubbles in tubing/transducer (highly compressible air absorbs kinetic energy), blood clots, compliant tubing, excessive stopcocks, arterial kinking.
Hydrostatic Leveling and Pressure Offsets
The transducer must be zeroed and leveled to a standardized anatomical landmark:
Standard Reference: The Phlebostatic Axis (4th intercostal space at the mid-axillary line, corresponding to the right atrium).
Neurosurgical / Sitting Position: Leveled to the External Auditory Meatus (Tragus / Circle of Willis) to accurately quantify cerebral perfusion pressure ( C P P = M A P − I C P CPP = MAP - ICP CPP = M A P − I CP ).
Hydrostatic Column Physics: 1 cm H 2 O = 0.735 mmHg ≈ 0.74 mmHg ( 1 mmHg = 1.36 cm H 2 O ) 1\text{ cm } H_2O = 0.735\text{ mmHg} \approx 0.74\text{ mmHg} \quad (1\text{ mmHg} = 1.36\text{ cm } H_2O) 1 cm H 2 O = 0.735 mmHg ≈ 0.74 mmHg ( 1 mmHg = 1.36 cm H 2 O )
If the transducer is positioned 10 cm 10\text{ cm} 10 cm BELOW the reference axis , hydrostatic pressure adds to the signal: blood pressure reads 7.4 mmHg 7.4\text{ mmHg} 7.4 mmHg falsely high .
If the transducer is positioned 10 cm 10\text{ cm} 10 cm ABOVE the reference axis , blood pressure reads 7.4 mmHg 7.4\text{ mmHg} 7.4 mmHg falsely low .
Depth of Anaesthesia Monitoring: Processed EEG
Processed electroencephalography (EEG) monitors quantify cortical electrical activity to gauge the hypnotic component of general anaesthesia.
The Bispectral Index (BIS)
BIS processes frontal bipolar EEG signals through mathematical algorithms combining four sub-components: beta ratio (high frequency activity), synch fast slow (bispectral phase coupling), burst suppression ratio ( B S R BSR BSR ), and QUAZI suppression.
BIS Numerical Scale (0 to 100):
- 100 100 100 : Fully awake, alert
- 60 − 80 60-80 60 − 80 : Sedated, conscious sedation
- 40 − 60 40-60 40 − 60 : Target range for general anaesthesia (low probability of explicit recall)
- 20 − 40 20-40 20 − 40 : Deep hypnotic state
- < 20 <20 < 20 : Burst suppression pattern
- 0 0 0 : Completely isoelectric EEG (cortical electrical silence)
- Paradoxical Readings and Clinical Pitfalls
Ketamine: Promotes high-frequency frontal beta and gamma oscillations ( 25 − 40 Hz 25-40\text{ Hz} 25 − 40 Hz ), causing BIS values to paradoxically rise to 70 − 90 70-90 70 − 90 despite deep surgical dissociative anaesthesia.
Nitrous Oxide: Produces fast cortical EEG patterns without altering BIS values significantly.
Hypothermia and Ischemia: Profound hypothermia ( < 32 ° C <32°\text{C} < 32° C ), severe hypotension, hypoglycemia, or cerebral ischemia reduce cortical metabolism, lowering BIS toward burst suppression independently of anaesthetic depth.
Electromyographic (EMG) Artifact: High-frequency scalp muscle shivering or electrical interference falsely elevates BIS values.
Advanced Cardiac Output Monitoring
Pulmonary Artery Catheter (PAC) Thermodilution: A known volume ( V i V_i V i ) of cold saline is injected into the right atrium. A distal thermistor in the pulmonary artery records temperature change over time. Cardiac output is calculated via the Stewart-Hamilton Equation : C O = V i ( T b − T i ) ⋅ K ∫ 0 ∞ Δ T b ( t ) d t CO = \frac{V_i (T_b - T_i) \cdot K}{\int_0^\infty \Delta T_b(t) \, dt} CO = ∫ 0 ∞ Δ T b ( t ) d t V i ( T b − T i ) ⋅ K The area under the thermodilution curve is inversely proportional to cardiac output : a low cardiac output produces a prolonged, tall curve (slow indicator clearance); a high cardiac output produces a small, narrow curve.
Pulse Contour Analysis (e.g., FloTrac, PiCCO): Derives stroke volume beat-to-beat by mathematical integration of the area under the systolic portion of the arterial pressure waveform, incorporating patient aortic compliance and systemic vascular resistance.
Transesophageal Echocardiography (TEE) and Doppler: Measures blood flow velocity across the aortic valve or descending aorta via Doppler shift, integrating velocity over time (Velocity-Time Integral, V T I VTI V T I ) multiplied by aortic cross-sectional area to determine stroke volume ( S V = V T I × Area SV = VTI \times \text{Area} S V = V T I × Area ).
Clinical Pearls and Exam Traps
Tip
The MAP Reliability Rule: Whether an arterial line system is severely underdamped (massive systolic overshoot) or severely overdamped (blunted systolic peak), the Mean Arterial Pressure (MAP) remains accurate . Because MAP represents the mathematical integral (area under the curve) over time, dynamic oscillation artifacts cancel out.
Note
Carboxyhemoglobin vs. Methemoglobin Trap: Remember that carboxyhemoglobin causes pulse oximeters to overestimate saturation near 100 % 100\% 100% because C O H b COHb CO H b mimics H b O 2 HbO_2 H b O 2 at 660 nm 660\text{ nm} 660 nm . In contrast, methemoglobin absorbs equally at 660 nm 660\text{ nm} 660 nm and 940 nm 940\text{ nm} 940 nm , driving the ratio to 1.0 1.0 1.0 and locking the displayed reading at ≈ 85 % \approx 85\% ≈ 85% .
Caution
Shark-Fin vs. Rebreathing on Capnography: A shark-fin waveform denotes expiratory airway obstruction (bronchospasm, COPD, kinked ETT) where Phase II and Phase III are sloped. Rebreathing of C O 2 CO_2 C O 2 is identified by an elevated Phase I baseline ( > 0 mmHg >0\text{ mmHg} > 0 mmHg ); the waveform shape itself may remain otherwise normal.